Study shows how low dose of cadmium produces deleterious stress in lung epithelial cells

Bay­er is eas­ing in­to the cell ther­a­py space through the open­ing of its first ded­i­cat­ed man­u­fac­tur­ing fa­cil­i­ty in Berke­ley, CA, to sup­port lat­er-stage clin­i­cal tri­als

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

Neumo­ra Ther­a­peu­tics, a brain dis­ease biotech born out of stitch­ing to­geth­er mul­ti­ple neu­ro­science star­tups, is look­ing to repli­cate its orig­i­nal play­book by com­ple­ment­ing its sev­en-drug